Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure

The phase 4 observational cohort study assessed the effectiveness and safety of the thrombopoietin receptor agonist avatrombopag in patients with chronic liver disease (CLD) and thrombocytopenia undergoing a procedure. Patients with CLD may have thrombocytopenia, increasing the risk of periprocedura...

Descripción completa

Detalles Bibliográficos
Autores principales: Satapathy, Sanjaya K., Sundaram, Vinay, Shiffman, Mitchell L., Jamieson, Brian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553023/
https://www.ncbi.nlm.nih.gov/pubmed/37800793
http://dx.doi.org/10.1097/MD.0000000000035208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553023/
https://www.ncbi.nlm.nih.gov/pubmed/37800793
http://dx.doi.org/10.1097/MD.0000000000035208

Ejemplares similares